This week, I sat down with Dr. Jane Vergnes, Director of Toxicology and Vice President, Scientific Affairs, here at B&C and its consulting affiliate, The Acta Group (Acta®), and Dr. Richard Engler, Director of Chemistry, at B&C and Acta.  We discussed the provocative question “is everything carcinogenic?”  In asking this question, Jane and Rich discuss the marketing and labeling implications of a cancer classification for a chemical substance found as an ingredient in a consumer or industrial product.  In today’s “informed consumer” market, product manufacturers are challenged as never before to contextualize the significance of a cancer classification or other hazard characteristic.  If Proposition 65 has taught us anything, it is that “over” warning dilutes the significance of important product information and dulls consumer awareness of information that could be communicated more meaningfully.

ALL MATERIALS IN THIS PODCAST ARE PROVIDED SOLELY FOR INFORMATIONAL  AND ENTERTAINMENT PURPOSES. THE MATERIALS ARE NOT INTENDED TO CONSTITUTE LEGAL ADVICE OR THE PROVISION OF LEGAL SERVICES. ALL LEGAL QUESTIONS SHOULD BE ANSWERED DIRECTLY BY A LICENSED ATTORNEY PRACTICING IN THE APPLICABLE AREA OF LAW.

©2021 Bergeson & Campbell, P.C.  All Rights Reserved